SciMed Biotech Podcast with Matthew Gdovin of Vitanova Biomedical

Light activated therapy pioneering cancer treatment at Vitanova Biomedical

This episode features an exciting conversation with Matthew Gdovin, the Founder and Chief Science Officer of Vitanova Biomedical. Delve into the technology behind Vitanova’s cancer treatments as Matthew explains their proprietary light-activated intracellular acidosis (LAIA) therapy, which targets cancer cells with precision. We'll explore how this innovative approach uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death, a technique poised to revolutionize cancer therapy. Matthew also shares insights from his rich career in cancer research, the challenges of bringing such technology from the lab to the clinic, and the future of cancer treatment innovations.